With Stricter Guidelines, Do You Have High Blood Pressure Now?

Nov 14, 2017
Originally published on November 21, 2017 9:46 am

You may not have had high blood pressure Sunday, but you may have it today. Even if your blood pressure hasn't changed a smidge. What's up?

The rules shifted Monday. It used to be that we encouraged people to adopt healthy behavior to keep their blood pressure down but didn't label someone as having hypertension until systolic blood pressure (the top number) exceeded 140 millimeters of mercury and/or the diastolic blood pressure (the bottom number) exceeded 90 mm Hg. Lots of people watch those numbers closely.

Now the American College of Cardiology and the American Heart Association have updated blood pressure guidelines that move the goal post for many people.

If you have heart disease, chronic kidney disease or diabetes, then your target now for systolic blood pressure has moved down to 130 and for diastolic blood pressure to 80. Same goes if your 10-year risk of having a heart attack or stroke is greater than 10 percent (determined by a calculator found here).

The focus on people who have a high likelihood of heart disease and stroke is an effort to maximize the health gains from risk reduction.

To decide whether the blood pressure targets should change, the ACC and AHA assembled 21 experts who reviewed all the relevant studies, including a landmark study by the National Institutes of Health that supported lower target levels. In the end, they were unanimous in endorsing a lower standard, believing it would reduce risk and be worth the extra medications for people at high risk. Importantly, they did not change the standard for low-risk individuals.

The big change is that we will end up labeling many more people with hypertension and recommending drug treatment for many more people, too. The hope is that more aggressive treatment will reduce life-threatening heart attacks and strokes.

My colleagues and I conducted an analysis to estimate how many people would be affected. We determined that among those ages 45 to 75, an additional 15 million more people are now considered to have hypertension. Overall, a majority of people — 63 percent — in this age group would now be said to have hypertension.

Among all Americans, another analysis suggests that more than 100 million have it.

The new guidelines would mean 8 million more people would be recommended to start blood pressure drugs and an additional 14 million would be advised to have their current therapy increased.

So what should people actually do?

This guideline should guide discussions between clinicians and patients about how people feel about taking drugs, how they tolerate drugs, and which strategies fit them best.

The days are pretty much over when doctors could walk into the office and tell people what to do, write a prescription and expect them to comply. Decisions about care shouldn't be edicts. When that happens patients tend to tune out and leave prescriptions unfilled.

Clinicians and patients need to work collaboratively to set goals, aware of guidelines and the particular situation of each person.

People vary in their preferences. Some people don't like to take pills or don't tolerate them well. Some people think that when 30 people need to take a pill for years for one person to benefit, it's a good deal; others disagree.

There are many choices for blood pressure medications, and they are inexpensive; most are generics. The right choice for each individual may vary — and it may require trying a few different approaches.

Particularly for people with a systolic blood pressure between 130 and 140 who are being advised to ratchet up treatment, there should be a discussion about what the reduction in risk, if achieved, would mean for them and what it would take to get there. We will need tools that help people make informed choices and customize the information to each person. It's high time to move away from suggesting that one type of medical advice should fit all — even among people with high risk, there are many individual differences.

Amid the fanfare associated with the new guidelines, there are also a few things that haven't changed. In America, far too many people don't know that their blood pressure is high — and too few have had the opportunity for effective treatment even with the old standards.

We need to make sure that all Americans know their blood pressure and understand their options. Moreover, there are many effective strategies to reduce blood pressure that don't involve drugs, but they are too infrequently pursued.

The so-called DASH diet, even moderate physical activity, avoiding obesity and reducing stress can all be effective. They may sound mundane, but they can help people avoid having to pop pills. We need to help people appreciate the power of these approaches and make it easy for them to pursue these lifestyle strategies.

Overnight, many people discovered that they are now considered to have high blood pressure. With so many people now being considered hypertensive, maybe we should start thinking of it as less of a clinical condition and more as an opportunity for many people to work on ways to promote better health.

Harlan Krumholz is a cardiologist and the Harold H. Hines Jr. professor of medicine at Yale School of Medicine. He directs the Yale-New Haven Hospital Center for Outcomes Research and Evaluation that developed the readmission measures for the Centers for Medicare & Medicaid Services.

Copyright 2018 NPR. To see more, visit http://www.npr.org/.


Here is a set of numbers to get used to - 130 over 80. That is the new, more strict threshold for high blood pressure. The previous numbers were 140 over 90. The American Heart Association and 10 other groups revised the guidelines yesterday after reviewing years of studies.

And with us to talk about this is Dr. Harlan Krumholz. He's a cardiologist with the Yale School of Medicine. Welcome to the show.


MCEVERS: So just remind us why blood pressure is such an important measure of health.

KRUMHOLZ: So blood pressure, which is really the force of blood as it's expelled from the heart, turns out to be a critically important factor in the risk of heart disease and stroke, eye disease, kidney disease. The higher your blood pressure, the higher your risk. And we've known for a long time that if we bring that blood pressure down, then we can bring people's risk down.

MCEVERS: So then what led to this shift from 140 over 90 to 130 over 80 as the new measure for what is considered to be high blood pressure?

KRUMHOLZ: So a big question's always been, what's the right blood pressure? Believe it or not, it was only in the 1970s that studies began to be done that helped us understand this. There are stories of people like FDR whose blood pressure was routinely in the 200s. And of course, he died in disease that was related to his hypertension. And it turns out that some recent studies have pushed us in the direction of thinking that lower is actually better and that the numbers that we had settled on before, this 140 over 90, for some people may be still too high.

Those studies, particularly an NIH study, a National Institutes of Health study that recently came out, really demonstrated to us the possibility that we could help people more by getting their blood pressure lower. Again, for the highest-risk people, that's what the guidelines are recommending.

MCEVERS: So does this mean, though, that people who are listening who thought they were fine should now actually be worried if they are in that higher number?

KRUMHOLZ: So first of all, nobody should be worried. I mean, the way you are today is no different than you were yesterday. This new target, the 130 over 80, is really within the guidelines being recommended for high-risk individuals, people whose risk based on their other risk factors is elevated. Second, I think it represents an opportunity for people. That is, it opens a discussion about whether they want to set a goal for themselves with their clinicians that is a little lower than it was before, that this is essentially giving permission to say, we can think about strategies that can bring people down lower. And it may provide a benefit for those people.

MCEVERS: This change in the measure for high blood pressure does mean that a lot more people, especially people under 45, are now considered hypertensive, and that there's no more pre-hypertension. Will this change how they are treated?

KRUMHOLZ: Yeah, well, you know, my goodness, there's so many more people that will be labeled now with high blood pressure. I worry a little bit that people start thinking they have a disease and instead of recognizing that they have an opportunity perhaps to lower their risk even more. I will say that there remains some controversy, especially about treating very much older people and their degree of tolerance of getting their blood pressure very low. But the guidelines are recommending broadly that tens of millions more people might consider intensifying their treatment - that is, increasing doses or increasing meds, or even starting treatment when they wouldn't have started it before.

I think our hope is that as a result there will be a drop in the number of strokes and heart attacks and that people will do better. But this needs to be a discussion with doctors and patients. One thing worth highlighting for which there's widespread agreement is that we could be doing a better job in this country in helping people lower their blood pressure without using drugs.

Diet and exercise and helping people achieve closer to their ideal weights can have dramatic effects on blood pressure. In fact, people taking blood pressure medicines now even with the new guidelines might not even have to take pills at all if they could modify their diets slightly - more fruits and vegetables, lower amounts of salt - and more physical activity, lower stress or stress reduction strategies. And so there's widespread agreement now that we really need to be pushing in this direction to make it easier for people to achieve these kind of lifestyle changes and not just default to drugs all the time.

MCEVERS: Cardiologist Harlan Krumholz with the Yale School of Medicine, thank you very much.

KRUMHOLZ: Thank you. Transcript provided by NPR, Copyright NPR.